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Over the years, a vast array of information concerning the interactions of viruses with
their hosts has been collected. However, recent advances in proteomics and other sys-
tem biology techniques suggest these interactions are far more complex than anticipated.
One particularly interesting and novel aspect is the analysis of cellular proteins incorpo-
rated into mature virions. Though sometimes considered puriﬁcation contaminants in the
past, their repeated detection by different laboratories suggests that a number of these
proteins are bona ﬁde viral components, some of which likely contribute to the viral life
cycles. The present mini review focuses on cellular proteins detected in herpesviruses. It
highlights the common cellular functions of these proteins, their potential implications for
host–pathogen interactions, discusses technical limitations, the need for complementing
methods and probes potential future research avenues.
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INTRODUCTION
Over the last decades, many host–pathogen interactions have
been characterized using genetics, biochemical, and microscopy
approaches. These discoveries relied onmutants, pharmacological
reagents, immunoprecipitations, immunoﬂuorescence, electron
microscopy, cell fractionation, andWestern blotting to name a few
of the methods employed. These approaches provided much pre-
cious information but, given the typical focus of these approaches
on individual molecules, likely only revealed a small portion of
the proteins involved. Other methods such as high throughput
two-hybrid and genetic screens, nucleic acid arrays, RNA interfer-
ence, and proteomics are now proving essential tools to tackle
the complexity of these interactions. The main advantages of
mass spectrometry, for instance, are that it is a fast, sensitive and
potentially a quantitative approach to identify putative novel play-
ers, particularly when coupled to efﬁcient puriﬁcation schemes.
Already, proteomics revealed how viruses modulate the expres-
sion of host proteins (Rassmann et al., 2006; Sun et al., 2008;
Tong et al., 2008; Antrobus et al., 2009; Pastorino et al., 2009;
Thanthrige-Don et al., 2009; Zandi et al., 2009; Zhang et al., 2009,
2010; Coombs et al., 2010; Emmott et al., 2010; Lu et al., 2010,
2012; Munday et al., 2010; Bartel et al., 2011; Lietzen et al., 2011;
Ramirez-Boo et al., 2011; Chou et al., 2012). A relatively new and
interesting ﬁeld is the characterization of host–pathogen inter-
actions within mature puriﬁed virions. As reviewed on several
occasions, several studies reported the presence of individual cel-
lular proteins in viral particles (Bernhard et al., 2005;Maxwell and
Frappier, 2007; Viswanathan and Fruh, 2007; Friedel and Haas,
2011; Zheng et al., 2011). This includes vaccinia virus (Krauss et al.,
2002), inﬂuenza virus (Shaw et al., 2008), HIV (Gurer et al., 2002;
Cantin et al., 2005;Ott, 2008), vesicular stomatitis virus (Moerdyk-
Schauwecker et al., 2009), and several herpesviruses (see below).
Though these cellular components have often been considered
puriﬁcation contaminants, the presence of similar proteins in both
related and unrelated viruses suggests that some of them may be
biologically relevant. The identiﬁcation of virion-associated host
proteins could thus lead to the discovery of novel therapeutic tools
against viruses. The present review focuses on their identiﬁcation
and putative roles with respect to the proteomics of herpesviruses.
PROTEOMICS OF HERPESVIRIONS
Thus far, the protein composition of eight different herpesviri-
ons has been studied by mass spectrometry. These studies include
the alphaherpesvirinae herpes simplex virus type 1 (HSV-1) and
pseudorabies virus (PRV;Loret et al., 2008;Kramer et al., 2011), the
betaherpesvirinae human andmurine cytomegaloviruses (HCMV
and MCMV, respectively; Kattenhorn et al., 2004; Varnum et al.,
2004) and the gammaherpesvirinae Kaposi sarcoma herpesvirus
(KSHV), gamma herpesvirus 68 (γHV68), Epstein–Barr virus
(EBV), and Alcelaphine (Bortz et al., 2003; Johannsen et al., 2004;
Bechtel et al., 2005; Zhu et al., 2005; Dry et al., 2008). Interest-
ingly, host proteins were detected in all herpesvirions analyzed so
far, as summarized in Table 1. For instance, our laboratory pre-
viously reported the protein composition of mature extracellular
HSV-1 viral particles and identiﬁed as many as 49 cellular proteins
(Loret et al., 2008). Similarly, studies focusing on PRV and EBV
reported up to 48 and 43 cellular proteins, respectively (Johannsen
et al., 2004; Kramer et al., 2011). Meanwhile, Varnum et al. (2004)
found asmany as 70 different host proteins in extracellularHCMV
virions.While fewer cellular proteins were reported for other viral
particles, it is clear that herpesviruses can potentially incorporate
many proteins from its host. Moreover, of the 173 different pro-
teins detected in herpesvirions, nine protein groups are present in
at least four distinct herpesvirions. This includes 14-3-3, actin,
annexins, coﬁlin, translation factors, GAPDH, heat shock pro-
teins, pyruvate kinase M2, and various Rab GTPases. These results
indicate that, ﬁrst of all, it is common for herpesviruses to incor-
porate cellular proteins into their viral particles and, secondly, that
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different viruses share similar host proteins.Most excitingly, it also
suggests that these host proteins may play common roles through-
out the herpesviral family. This deﬁnes an interesting and novel set
of host–pathogen interactions taking place within the virus itself,
rather than the cell.
It is tempting to speculate that some viruses might have a
higher capacity to steal cellular proteins because of their size and
symmetry. Herpesviruses are indeed large viruses containing a
layer called the tegument between their capsids and envelopes
that could accommodate non-viral proteins. Though some host
proteins may randomly be incorporated into virions, others may
rather be selected to insure the optimal replication of the viruses
that carry them.
PUTATIVE FUNCTIONS OF HOST PROTEINS ASSOCIATED
WITH HERPESVIRIONS
Bioinformatics databases such as the KEGG, Gene Ontology, or
DAVID are useful tools to get an overview of the functional inter-
play of proteins (Ashburner et al., 2000; Huang Da et al., 2009;
Kanehisa et al., 2010). As pointed out by Friedel and Haas (2011),
complex statistical tools are available to quantitatively evaluate the
implication of proteins in various processes but these are beyond
the scope of the present review. Here an analysis of the proteins
identiﬁed inherpesvirionswas insteadperformedwith the Ingenu-
ity Pathways Analysis database (Ingenuity® Systems), which con-
tains all the known physical and functional links among cellular
proteins and deﬁnes theirmost signiﬁcant functions. That analysis
indicates that many of the cellular proteins found in herpesvirions
normally modulate trafﬁcking, cell proliferation, cell death, cell
migration, cell metabolism, or the cytoskeleton (Figure 1, upper
pie chart). Though subtle differences between family members are
noticeable when looking at individual viruses, similar functions
are found (Figure 1, other charts). Immune-related molecules are
also important constituents for several viruses, including HSV-1,
KSHV, γHV68,Alcelaphine, and MCMV. Altogether, this provides
an overall picture whereby herpesviruses, not surprisingly, mod-
ulate all of the important aspects of the cell but where each virus
might deploy its energies slightly differently. The main surprise is
that so many cellular proteins are detected within assembled viral
particles, which raises an important question as to their biological
signiﬁcance and mode of action.
IMPLICATIONS OF VIRION-ASSOCIATED HOST PROTEINS
FOR HERPESVIRUSES
The overall picture that several important cellular functionsmight
bemodulated by the host proteins incorporated into viral particles
is intriguing. This clever strategy is consistent with the parasitic
nature of all viruses, including herpesviruses, which would pre-
sumably gain some replication advantage from stealing cellular
modulators rather than coding for them in their own genomes.
Themost critical question is the beneﬁt for the viruses to incorpo-
rate these cellular proteins in their assembled particles, particularly
since these proteins also exist in the cells. While this is open
to discussion, one possibility is that some of the incorporated
cellular proteins may be remnants of the ﬁnal capsid envelop-
ment process. Alternatively, this may allow the prompt action of
some of these proteins immediately upon viral entry. This could
jumpstart the expression and/or duplication of the viral genome,
as it is the case for the herpesviral VHS, VP16, ICP0, and ICP4
proteins that are present in virions (Lam et al., 1996; Everett, 2000;
Halford and Schaffer, 2001; Ellison et al., 2005; Hancock et al.,
2006; Loret et al., 2008; Sarma et al., 2008; Loret and Lippe, 2012).
Other early potential sites of action are the process of viral entry
itself, intracellular capsid transport, import of the viral genome
through the nuclear pore or immune modulation, all common
steps among herpesviruses. Whatever the case might be, the ques-
tion remains as to why the cellular pool of these proteins would
not sufﬁce. Several options may be considered. First, it may be
that the virions incorporate speciﬁc isoforms, splice variants or
post-translationally modiﬁed proteins that could have properties
or functions distinct than their cellular counterparts. Second, the
incorporation of a host protein from one cell type might permit
the infection of a different cell type that does not express such
protein. For example, alpha herpesviruses initially infect mucosal
cells and could acquire host proteins that are beneﬁcial to infect
dormant neuronal cells. Finally, the host proteinsmight be in com-
plex with viral proteins and it is those complexes that are active to
promote the infection. These possibilities are of course speculative
at this point and need to be explored.
One aspect where the incorporation of host proteins in mature
virions might be beneﬁcial is molecules involved in intracellu-
lar trafﬁcking.Work by numerous laboratories demonstrated that
the transport machinery used to move cellular proteins is also
employed by viruses (Simons and Warren, 1984; Lodish et al.,
2000; Sollner, 2004; Greber and Way, 2006; Mercer et al., 2010).
This is essential for their proteins and particles to reach their ﬁnal
destination, for example, the site of viral replication, assembly,
and/or envelopment. Along with SNARES proteins, Rab and Arf
GTPases are master regulators of molecular trafﬁcking through-
out the cell (Sollner andRothman,1996; Zerial andMcBride, 2001;
Mizuno-Yamasaki et al., 2012). So far,VAMP3, a SNARE,was iden-
tiﬁed in PRV virions (Kramer et al., 2011) but it may only be a
matter of time until other SNARES are discovered in other mem-
bers of the herpes family. This is relevant as another SNARE was
reported to facilitate the envelopment of MCMV capsids (Cepeda
and Fraile-Ramos, 2011). In contrast, a great number of Rab pro-
teins have been identiﬁed in herpesvirions, particularlyHSV-1 and
PRV (Table 1). One stimulating option is that these proteins reg-
ulate the displacement of viral capsids in the cell, which could
justify their incorporation in the viral particles. As Rab and Arf
proteins collectively modulate several intracellular transport steps
within the cell, it is anticipated they may be involved in various
stages of the infection. For instance, Rab1, which is present in
HSV-1 extracellular virions (Loret et al., 2008), and Rab43 were
recently demonstrated to modulate the ﬁnal envelopment of the
virus (Zenner et al., 2011). Similarly, Rab6, found in HSV-1 and
PRV(Loret et al., 2008;Kramer et al., 2011), is alsonecessary for the
efﬁcient assembly of the relatedHCMV(Indran andBritt, 2011). It
will now be of interest to determine if the virion-associated pool of
these GTPases actively participates in the viral life cycle. Interest-
ingly, several Rab proteins have been implicated in autophagosome
formation and maturation (Chua et al., 2011). While it is difﬁcult
to consider how virion-incorporated Rab proteins play a role at
that stage, they might rather be incorporated into the virions as
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FIGURE 1 |The proteins fromTable 1 were analyzed with the Ingenuity
database to define their putative functions in the context of an infection.
To this end, the protein accession numbers (or GI numbers) were queried
from the Ingenuity database. For the purpose of this ﬁgure, all known
functions associated with these proteins were exported to Microsoft Excel
and regrouped. In the top pie chart, the cellular proteins found in all the
herpesvirions were analyzed collectively, while the other pie charts depict the
host proteins incorporated into each virus. Since each protein can be
associated with multiples functions in the database, the results of those
analyses are expressed as relative values instead of raw numbers, which
consequently exceeds the original number of proteins analyzed. The
percentages therefore represent the number of proteins falling into a given
category with the total of each pie chart being 100%. A graphical legend of
the categories is provided at the bottom right corner of the ﬁgure.
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a consequence of their involvement in autophagosome formation
and concomitant viral envelopment. Given the vast impact of Rab
proteins on the cell, it will be a major challenge to decipher all
their roles in the life cycle of herpesviruses, particularly for the
pool present in mature virions.
Molecular trafﬁcking is not only dependent on SNARES, Rab,
and Arf proteins, it is also intimately linked to the cytoskeleton.
It is thus not surprising that herpesviruses devote some of their
resources toward regulating this central cellular machinery. For
instance, herpesviruses signiﬁcantly reorganize both cellular and
nuclear actin as well asmicrotubules (Norrild et al., 1986;Avitabile
et al., 1995; Sharma-Walia et al., 2004; Simpson-Holley et al., 2005;
De Regge et al., 2006; Saksena et al., 2006). They also travel along
microtubules during both entry and egress and interact with sev-
eral cellular molecular motors (Sodeik et al., 1997; Smith et al.,
2001; Dohner et al., 2002; Marozin et al., 2004; Lee et al., 2006;
Wolfstein et al., 2006; Radtke et al., 2010) as well as cortical and
nuclear actin ﬁlaments (Forest et al., 2005; Feierbach et al., 2006;
Roberts and Baines, 2011). Furthermore, some members incor-
porate in their viral particles tubulin or actin-related components
(Table 1; Wong and Chen, 1998; Grunewald et al., 2003). Actin
has been reported to compensate the loss of various viral tegu-
ment proteins in PRV (del Rio et al., 2005; Michael et al., 2006)
and may thus act as an abundant ﬁlling agent, so its signiﬁcance
in herpesviral particles remains enigmatic. Similarly, the relevance
of intermediate ﬁlament components vimentin and keratins in
some herpes virions (Table 1) is difﬁcult to assess given these ﬁla-
ments are not as well characterized as other cytoskeletal elements.
It may nevertheless be important for herpesviruses, particularly
since they are not all associated with the common skin or hair
contaminants often detected in mass spectrometry (Hertel, 2011).
Viruses tend to monopolize for their own purpose their host
expression apparatus, including protein translation (Bushell and
Sarnow, 2002). For example, the prototypic HSV-1 ICP27 viral
protein regulates all aspect of mRNAs including transcription,
splicing, nuclear export, and translation for the beneﬁt of the virus
(Rice and Knipe, 1988; Sekulovich et al., 1988; Sandri-Goldin and
Mendoza, 1992; Smith et al., 1992; Hardwicke and Sandri-Goldin,
1994; Hardy and Sandri-Goldin, 1994; Brown et al., 1995; Soli-
man et al., 1997; Chen et al., 2002; Lindberg and Kreivi, 2002;
Ellison et al., 2005; Larralde et al., 2006; Fontaine-Rodriguez and
Knipe, 2008). As these cellular functions are highly regulated, the
inclusion of DDX3X, a multifunctional RNA helicase that also
regulates transcription, nuclear export, and translation that is
used by several viruses (Schroder, 2010, 2011) may be relevant.
Its incorporation into mature virions could thus accelerate viral
gene expression in the early stages of the infection. Similarly, the
presence of translation initiation or elongation factors in viri-
ons (Table 1) may also jumpstart gene expression in favor of the
viruses.
Interestingly, HSV-1 does not require cells to be in the S-phase
and even arrests the cell cycle at the G1/S transition step (Shadan
et al., 1994; Song et al., 2000), which partly explains why it can
grow in non-dividing neurons. While the precise mechanism of
this arrest is unclear, it is known that the viral ICP0 protein and
the VP16 cellular partner HCF modulate the cell cycle (Hobbs
and DeLuca, 1999; Lomonte and Everett, 1999; Piluso et al., 2002).
Moreover, ICP0 interacts with the host cyclinD3 (Kawaguchi et al.,
1997). However, it was recently reported that stress, rather than the
cell cycle per se, may be a critical feature (Bringhurst and Schaf-
fer, 2006). Clearly, the interaction of herpesviruses with the cell
proliferation apparatus is complex and likely involves several host
and viral proteins. Identifying novel players that might be incor-
porated into mature virions may thus be very useful to clarify this
process.
An interesting scenario is the possible regulation of apoptosis
by host proteins loaded onto viral particles. Apoptosis is regu-
lated both negatively and positively by several viruses (Teodoro
and Branton, 1997; Goodkin et al., 2004), presumably to insure
their survival at the early stages of the infection but their efﬁcient
release later on. Conceptually, the presence of anti-apoptotic pro-
teins in herpes particles might thus provide a mean to quickly
evade death upon entry, while the presence of pro-apoptotic pro-
teins on newly assembled/enveloped viral particles may trigger or
stimulate their extracellular release. Only further work will resolve
this open question.
TECHNICAL LIMITATIONS
Several factors generally contribute to variation among proteomic
studies. Hence, the preparation of the samples (e.g., in-gel trypsin
digestion versus liquid digestion and chromatography) may lead
to the detection of different populations of tryptic peptides.More-
over, the sensitivity of the mass spectrometers and the abundance
of the proteins in the samples also impact peptide detection.
The relative abundance of a peptide is itself inﬂuenced by the
complexity of the samples, where some proteins may evade iden-
tiﬁcation. Finally, each protein differs in its properties (ionization,
resolution in SDS-PAGE gels), which will be reﬂected in their
detection. This includes SNARES, which are transmembrane pro-
teins resistant to SDS extraction (Yang et al., 1999; Kubista et al.,
2004). It is thus likely that some of the proteins in Table 1 are
present in more viral particles than reported and that additional
proteins are indeed incorporated in herpesvirions. More speciﬁc
aspects regarding herpesviruses includes the puriﬁcation schemes
employed to enrich the viral particles, which will directly inﬂu-
ence the purity of the samples and hence the potential detection
of contaminants. One important caveat is that some host proteins
may simply stick to the large viral particles. Another one is com-
mon contaminants such as some hair/skin associated keratins or
as mentioned above actin, which may simply ﬁll the virions. How-
ever, evenpotential contaminants cannot simply bediscarded since
actin and even some keratins may indeed participate in viral life
cycles. Moreover, the relative abundance of all the cellular proteins
within the cell is unknown, so it is not possible to rule out potential
contaminants on the sole basis of abundance. It is thus critical to
orthogonally validate all proteomics hits.
Various tools are available to deﬁne the biological relevance
of host proteins identiﬁed in viral particles, including Western
blotting, immuno-electronmicroscopy or functional screens. One
powerful method is RNA interference. However, given the dual
presence of the host proteins within the viral particles and the cell
itself, this becomes a challenging task. RNA interference also has
its own caveats (false positives and negatives). Another common
step is the expression of dominant positive or negative mutants.
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In all cases, one major difﬁculty is that the host proteins may be
essential for the cells and their depletion may lead to cytotoxicity,
thus proper controls are needed. In addition, the host proteins
might be essential for the virus within the cells but only acces-
sory within the virions. Consequently, depletion of a protein may
have limited impact on the virus since complemented by the other
pool of that protein in the virus or the cell. Small reduction or
stimulation in viral yields may thus result. It such cases, it may
be necessary to produce the virus on cells that lack these proteins
to see if this makes a difference. One should also consider ani-
mal models since tissue culture based screens may miss important
players, for instance modulators of the immune system or viru-
lence factors. Clearly, multiple experimental strategies are needed
to ultimately insure the biological signiﬁcance of the host proteins
found in viral particles.
CONCLUDING REMARKS AND FUTURE DIRECTIONS
The identiﬁcation and functions of host proteins in viral particles
is an important step toward the elucidationof novel host-pathogen
interactions. In the case of herpesvirions, this is well under way
with eight different family members analyzed so far. One main
aspect is to sort biologically relevant cellular proteins from sticky
contaminants. The orthogonal validation of the host proteins
found in herpesvirions using biologically relevant assays is thus
critical. As pointed out above, it will necessary to analyze all these
proteins in the background of two pools, one cellular and one
virion-associated, which are likely to complement one another.
An interesting possibility is that some isoforms or speciﬁc post-
translationally modiﬁed host proteins may be loaded into the
capsids. Thus a detailed analysis of the host proteins present in
viral particles will be important and a potential way to distinguish
them from their cell-associated counterparts. Another issue is the
expected variation among cell types. In that respect, it would be
most interesting to examine the cellular protein content of HSV-
1 produced in neurons in opposition to the virions produced
on other cell types. Finally, the mechanisms by which all these
host proteins are recruited to the viral particles will also need to
be explored. Thus the proteomics of viral particles is only the
beginning of the adventure, which should prove most exciting yet
challenging.
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